Blet, Alice
McNeil, Joel B.
Josse, Julie
Cholley, Bernard
Cinotti, Raphaël
Cotter, Gad
Dauvergne, Agnès
Davison, Beth
Duarte, Kévin
Duranteau, Jacques
Fournier, Marie-Céline
Gayat, Etienne
Jaber, Samir
Lasocki, Sigismond
Merkling, Thomas
Peoc’h, Katell
Mayer, Imke
Sadoune, Malha
Laterre, Pierre-François
Sonneville, Romain
Ware, Lorraine
Mebazaa, Alexandre
Kimmoun, Antoine
Clinical trials referenced in this document:
Documents that mention this clinical trial
Gender and survival of critically ill patients: results from the FROG-ICU study
https://doi.org/10.1186/s13613-019-0514-y
Association between in-ICU red blood cells transfusion and 1-year mortality in ICU survivors
https://doi.org/10.1186/s13054-022-04171-1
Article History
Received: 16 May 2022
Accepted: 16 September 2022
First Online: 7 October 2022
Declarations
:
: The FROG-ICU study was conducted in France and Belgium in accordance with Good Clinical Practice (Declaration of Helsinki 2002) and Ethical Committee approvals (Comité de Protection des Personnes – Ile de France IV, IRB No. 00003835 and Commission d’éthique biomédicale hospitalo-facultaire de l’hôpital de Louvain, IRB No. B403201213352). The Ethical Committees waived the need for written consent; all patients and/or next of kin were informed and oral consent documented in the patients’ medical records by the investigator.
: Not applicable.
: The authors declared that they have no conflict of interest related to the present work.